BHSRX Holdings Information

BHSRX is a mutual fund with a total of 142 individual holdings. The top holdings are Eli Lilly and Company stock at 11.92%, Johnson & Johnson at 8.03%, Merck & Co. at 5.56%, AbbVie at 5.07%, and Thermo Fisher Scientific at 4.41%.

Total Holdings

142

Top 10 Percentage

53.34%

Asset Class

Equity

Fund Category

Health

Assets

6.26B

Forward PE Ratio

n/a

Breakdown by Asset Class

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	LLY	Eli Lilly and Company	11.92%	656,650
2	JNJ	Johnson & Johnson	8.03%	1,924,600
3	MRK	Merck & Co., Inc.	5.56%	2,400,258
4	ABBV	AbbVie Inc.	5.07%	1,261,298
5	TMO	Thermo Fisher Scientific Inc.	4.41%	455,530
6	UNH	UnitedHealth Group Incorporated	4.33%	708,976
7	GILD	Gilead Sciences, Inc.	4.09%	1,783,230
8	AMGN	Amgen Inc.	3.98%	590,203
9	VRTX	Vertex Pharmaceuticals Incorporated	3.33%	390,198
10	ABT	Abbott Laboratories	2.61%	1,509,463
11	PFE	Pfizer Inc.	2.40%	5,365,585
12	DHR	Danaher Corporation	2.29%	682,443
13	EW	Edwards Lifesciences Corporation	2.27%	1,594,693
14	ELV	Elevance Health, Inc.	1.86%	302,439
15	SYK	Stryker Corporation	1.80%	354,942
16	BMY	Bristol-Myers Squibb Company	1.77%	1,690,485
17	ARGX	argenx SE	1.54%	95,059
18	BIIB	Biogen Inc.	1.24%	364,188
19	TEVAN.MX	Teva Pharmaceutical Industries Ltd ADR	1.21%	2,140,996
20	RVMD	Revolution Medicines, Inc.	1.17%	361,340
21	WAT	Waters Corporation	1.13%	174,359
22	IQV	IQVIA Holdings Inc.	1.08%	262,637
23	MRNA	Moderna, Inc.	0.98%	444,967
24	ILMN	Illumina, Inc.	0.95%	284,747
25	DXCM	DexCom, Inc.	0.95%	663,769

Showing 25 of 142 holdings

Subscribe to see the full list

Activate Now

As of Aug 31, 2026